Most cancer patients believe surgery will be curative

October 8, 2015

Most cancer patients believe surgery will be curative
(HealthDay)—Most patients undergoing surgery for lung or colorectal cancer believe that the surgery is likely to be curative, according to a study published in the Oct. 15 issue of Cancer.

Yuhree Kim, M.D., from Johns Hopkins University in Baltimore, and colleagues characterized the prevalence of the expectation that of lung or colorectal cancer might be curative among 3,954 patients who underwent cancer-directed surgery for lung (30.3 percent) or colorectal (69.7 percent) cancer. Patients were identified from a population-based and health system-based survey of participants from multiple U.S. regions.

The researchers found that 80.0 percent of patients with lung cancer and 89.7 percent of those with colorectal cancer responded that surgery would cure their cancer. Even among patients with stage IV lung and , 57.4 and 79.8 percent, respectively, believed surgery was likely to be curative. The odds ratio (OR) of the perception of curative intent was higher among patients with colorectal versus (OR, 2.27). Higher odds of perceiving surgery would be curative were also seen among patients who reported optimal physician communication scores (score of 80 to 100 versus reference score of 0 to 80; OR, 1.40) and those reporting a shared role in decision-making with their physician (OR, 1.16) or family (OR, 1.17). Patients who were less likely to believe that would cure their cancer were unmarried female with an advanced tumor stage and a higher number of comorbidities.

"Greater focus on patient-physician engagement, communication, and barriers to discussing goals of care with who are diagnosed with cancer is needed," the authors write.

Explore further: Second primaries for over 25 percent with metastatic prostate cancer

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Second primaries for over 25 percent with metastatic prostate cancer

April 23, 2015
(HealthDay)—More than one-quarter of patients with metastatic prostate cancer present with a synchronous second primary malignancy, according to a review published in the April issue of The Journal of Urology.

EHR triggers cut time to diagnostic cancer evaluation

September 18, 2015
(HealthDay)—Electronic health record-based triggers may cut time to diagnostic evaluation of colorectal and prostate cancer, according to a study published online Aug. 24 in the Journal of Clinical Oncology.

Patients over 65 have more complications after colorectal cancer surgery

April 9, 2014
Most colorectal cancer surgeries are performed on patients older than 65 years, and older patients have worse outcomes than younger patients, although the total number of colon cancer operations has decreased in the past ...

Follow-up tests improve colorectal cancer recurrence detection

January 14, 2014
Among patients who had undergone curative surgery for primary colorectal cancer, the screening methods of computed tomography and carcinoembryonic antigen each provided an improved rate of surgical treatment of cancer recurrence ...

Lung cancer survival rates improve with CT scan follow-up

September 27, 2015
Patients with recurrent lung cancer have better post-surgery survival rates if their management includes a follow-up programme based on computer tomography (CT) of the chest, according to new findings.

Dual-modality DRS-FS discerns tumor from surrounding tissue

September 8, 2015
(HealthDay)—Dual-modality diffuse reflectance spectroscopy-fluorescence spectroscopy (DRS-FS) can differentiate tumor tissue from surrounding tissue in patients undergoing colorectal cancer resection, according to a study ...

Recommended for you

A molecule for fighting muscular paralysis

November 19, 2018
Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva (UNIGE), ...

New drug discovery could halt spread of brain cancer

November 19, 2018
The tissues in our bodies largely are made of fluid. It moves around cells and is essential to normal body function.

Use genetic data to predict the best time of day to give radiotherapy to breast cancer patients, say researchers

November 19, 2018
A new clinical study led by the University of Leicester and conducted in the HOPE clinical trials facility at Leicester's Hospitals has revealed the pivotal role that changing the time of day that a patient receives radiotherapy ...

New blood test detects early stage ovarian cancer

November 19, 2018
Research on a bacterial toxin first discovered in Adelaide has led to the development a new blood test for the early diagnosis of ovarian cancer—a disease which kills over 1000 Australian women and 150,000 globally each ...

New dual-action cancer-killing virus

November 19, 2018
Scientists have equipped a virus that kills carcinoma cells with a protein so it can also target and kill adjacent cells that are tricked into shielding the cancer from the immune system.

From the ashes of a failed pain drug, a new therapeutic path emerges

November 16, 2018
In 2013, renowned Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, Ph.D., and chemist Kai Johnsson, Ph.D., his fellow co-founder at Quartet Medicine, believed they held the key to non-narcotic pain relief. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.